captured official filings
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY
Semnur Pharmaceuticals, Inc.
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filings
WHAT THIS AUTOMATES
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
PROFESSIONAL DELIVERY LAYER
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
MACHINE-DETECTED FILING CHANGE RADAR
Public registration text delta
Comparing S-1 filed 2025-10-21 with S-1/A filed 2025-12-19.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- shares112 → 77-35
- control20 → 27+7
- management20 → 23+3
- going concern11 → 12+1
- risk factor12 → 11-1
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
New in latest filing
- See sections of this prospectus titled “ Description of Securities ” and “ Certain Relationships and Related Party Transactions .” Emerging Growth Company We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act.
- In Note 1 under the subsection titled “ Liquidity and Going Concern ” of our financial statements for the period ended September 30, 2025 included elsewhere in prospectus, we disclose that there is substantial doubt about our ability to continue as a going concern.
- We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission process, potential threats to our intellectual property rights and the manufacturing, marketing, distribution and sales efforts of any future collaborator.
Present in earlier filing, not found in latest
- See sections of this prospectus titled “ Description of Securities ” and “ Certain Relationships and Related Party Transactions .” Recent Developments Securities Purchase Agreement On September 23, 2025, Semnur entered into a Securities Purchase Agreement (“Biconomy SPA”) with Biconomy.
- In Note 3 titled “ Liquidity and Going Concern ” of our financial statements included elsewhere in prospectus, we disclose that there is substantial doubt about our ability to continue as a going concern.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
DOWNLOAD EDITION
Turn this issuer page into a project-file deliverable.
US$29 one time. For the moment you need to preserve the official record, hand it to a colleague or attach it to a deal file. No subscription, account or recurring charge. Download begins in this browser after payment is verified.
- Source-linked filing chronology and registration path
- Filing-change radar plus financing, legal, tax/lien and regulatory disclosure cues
- Official-source index for project-file archiving and downloadable CSV export
Best used whenYou need a dated, source-linked issuer record for a client, counsel, broker-dealer or internal review file.
Pay once · verified PayPal checkout · immediate HTML and CSV delivery.
AUTOMATED EVIDENCE SNAPSHOT
Unlock download · US$29Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
PUBLIC-RECORD DISCLOSURE SCREEN
Financing, legal and disclosure cues
Machine screening of the latest readable SEC filing text. It surfaces language for review; it does not label an issuer, confirm an event or produce a risk score.
TERM CUES OBSERVED72
Financing disclosure cues
Convertible instruments, placements and financing-agreement wording in screened SEC filing text.
- 424B3 · 2026-07-07 · SEC source
“…k, par value $0.0001 per share (“Common Stock”), issuable upon the exercise of (i) 510,000 private placement warrants (the “Private Warrants” and such shares issuable upon exercise, the “Private Warrant Shares”) originally sold in a private placement in conn…”
- 8-K · 2026-07-07 · SEC source
“…her the shares of Company Common Stock that may be issued in the Proposed Investment will be issued in a private placement. If such shares are issued in a private placement, the Company expects that (i) such shares would be issued to iHolding in a transaction exempt from registration under the Secur…”
TERM CUES OBSERVED2
Legal-proceeding disclosure cues
Litigation and legal-proceedings wording in screened SEC filing text.
- 424B3 · 2026-07-07 · SEC source
“…mination, or a failure by the parties to agree on the Definitive Agreements, could result in disputes or litigation relating to the interpretation, enforceability and/or performance of the provisions of the Term Sheet, which could be costly and/or time-consuming, divert management attention and/or o…”
- 8-K · 2026-07-07 · SEC source
“…mination, or a failure by the parties to agree on the Definitive Agreements, could result in disputes or litigation relating to the interpretation, enforceability and/or performance of the provisions of the Term Sheet, which could be costly and/or time-consuming, divert management attention and/or o…”
NO TERM CUE OBSERVED0
Tax / lien disclosure cues
Tax-liability and lien wording in screened SEC filing text.
No matching term was found in the 4 readable SEC filings screened.NO TERM CUE OBSERVED0
Regulatory disclosure cues
Agency inquiry, enforcement and trading-status wording in screened SEC filing text.
No matching term was found in the 4 readable SEC filings screened.View screened SEC sources (4)
Coverage boundary: this is a keyword screen of selected SEC filings only. It is not a court-docket search, tax-compliance review, lien clearance, sanctions screen, adverse-media search or a complete count of financings. A zero result means no matching term in the readable documents screened—not that the underlying issue is absent. Verify each cue in the linked official filing and use the appropriate independent professionals.
CAPITAL & OFFERING RECORD
Browse all captured financing filings →Official filing path for financing review
Registration, amendment, prospectus, shelf and current-report nodes are organized here as a reading path. Use the SEC source for terms, status and materiality.
- 424B3Prospectus / offering documentOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 424B3Prospectus / offering documentOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 424B3Prospectus / offering documentOpen SEC source →
- 424B3Prospectus / offering documentOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 424B3Prospectus / offering documentOpen SEC source →
- S-1/ARegistration amendmentOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- S-1Initial registration statementOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 424B3Prospectus / offering documentOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
Interpretation boundary: filing counts are not financing-round counts, proceeds, closing status or current capitalization. A registration, prospectus or report can relate to different purposes; use the linked official filing and appropriate advisers to verify each event.
KEY OFFERING LANGUAGE
What the latest offering documents say
Candidate sentence excerpts from readable official SEC filing text. This provides a fast reading layer for offering structure and terms; it is not a normalized term sheet or a transaction conclusion.
Offering structure
Candidate language describing the securities or registration structure.
“Under this shelf registration process, the Selling Securityholders may, from time to time, sell the securities offered by them described in this prospectus.”424B3 · 2026-06-15 · Open SEC source →
Shares / price
Candidate language about shares, units or offering-price terms.
“We are registering the issuance by us of up to 6,922,122 shares of Common Stock upon the exercise of the Public Warrants as required under the terms of the Warrant Agreement, dated as of April 6, 2022, between Denali Capital Acquisition Corp. (now known as Semnur Pharmaceuticals, Inc.), and VStock Transfer, LLC (“VStock”), as warrant agent, which governs the Public Warrants.”424B3 · 2026-07-07 · Open SEC source →
Use of proceeds
Candidate language describing stated proceeds or intended use.
“Unregistered Sales of Equity Securities and Use of Proceeds 102 Item 3.”424B3 · 2026-06-15 · Open SEC source →
Convertible / warrant terms
Candidate language about conversion, warrants or related instruments.
“Subsidiary Guarantee to Scilex-Oramed Note On September 21, 2023, Scilex entered into, and consummated the transactions contemplated by, a Securities Purchase Agreement (the “Scilex-Oramed SPA”) with Oramed Pharmaceuticals Inc. (“Oramed”) and the Agent (as defined below), pursuant to which, among other things, Scilex issued to Oramed a senior secured promissory note due 18 months from the date of is”424B3 · 2026-06-15 · Open SEC source →
View offering documents screened (5)
Extraction boundary: wording can be incomplete, duplicated, conditional or superseded by later filings. The system does not calculate proceeds, share counts, dilution or closing status from these excerpts. Verify every term in the linked official SEC filing.
OFFICIAL SEC SUBMISSIONS
Open Evidence Snapshot →Captured filing chronology
- 424B3Registration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 424B3Registration & offeringOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 424B3Registration & offeringOpen SEC filing →
- 424B3Registration & offeringOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- DEF 14AGovernanceOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 424B3Registration & offeringOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- S-1Registration & offeringOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 424B3Registration & offeringOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- DEF 14AGovernanceOpen SEC filing →
- PRE 14AGovernanceOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- SC 13G/AOwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- SC 13G/AOwnershipOpen SEC filing →
- SC 13G/AOwnershipOpen SEC filing →
- SC 13G/AOwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- SC 13G/AOwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- SC 13G/AOwnershipOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.